Target intelligence / Profile preview

Essential amino acid transamination

Molecular classification
Enzyme-mediated reaction, Aminotransferase/Transaminase family (enzymes involved)
01

Overview

Transamination of essential amino acids refers to the enzymatic process where an amino group from an *essential amino acid* (such as valine, leucine, isoleucine, lysine, etc.) is transferred to an α-keto acid, forming a new amino acid and a new keto acid. This reaction is catalyzed by aminotransferase (transaminase) enzymes, which require pyridoxal phosphate (vitamin B6) as a cofactor. While most amino acids (both essential and non-essential) undergo transamination as part of their metabolism, transamination is especially important for synthesizing non-essential amino acids and for the catabolism of amino acids. The process is fundamental to nitrogen balance and the biosynthetic and degradative pathways of amino acids. Specific aminotransferases (such as ALT and AST) are widely used as clinical biomarkers for liver health. Because "essential amino acid transamination" describes a class of biochemical reactions catalyzed by multiple enzymes rather than a unique molecular target or receptor, it is not itself a therapeutic target[1][3][4].

Other names
Transamination of essential amino acidsAminotransferase reaction (for essential amino acids)Aminotransferase-mediated transamination
02

Mechanism of action

Transfer of amino group from an essential amino acid to an α-keto acid, catalyzed by aminotransferase/transaminase enzymes, requiring pyridoxal phosphate (PLP; active form of vitamin B6) as a coenzyme[1][2]

03

Biological functions

Amino acid metabolismNitrogen metabolismSynthesis and degradation of amino acidsInterconversion of amino acidsConnection of protein metabolism with carbohydrate and lipid metabolism
04

Disease associations

Liver disease (when specific aminotransferases, such as ALT/AST, are elevated indicating liver damage)Inherited metabolic disorders of amino acid metabolism
05

Safety considerations

Deficiency or overactivity can disrupt amino acid and nitrogen metabolismvitamin B6 deficiency impairs reactionelevated aminotransferase levels indicate liver or muscle damage
06

Interacting drugs

Pyridoxine (Vitamin B6, as a required cofactor)

1 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST) used clinically as biomarkers for liver function/damage

Beyond the preview

Go deeper on Essential amino acid transamination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Essential amino acid transamination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call